Chase Therapeutics Corp

Pharmaceutical company · Washington, District of Columbia, United States

Chase Therapeutics Corp is a pharmaceutical company headquartered in Washington, District of Columbia, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Chase Therapeutics at a glance

Typepharmaceutical company
HeadquartersWashington, District of Columbia, United States
Earliest incorporation on record2017
SEC CIK1723805

What does Chase Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $4 million sold (2018).

Frequently asked questions about Chase Therapeutics

Where is Chase Therapeutics headquartered?

Chase Therapeutics Corp is headquartered in Washington, District of Columbia, United States.

What does Chase Therapeutics do?

Chase Therapeutics Corp is a pharmaceutical company.

When was Chase Therapeutics founded?

The earliest incorporation on record for Chase Therapeutics Corp is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences